Evaluation of the Hepatoprotective Effects of a Nutritional Supplement in Patients With Liver Disease Secondary to Chronic Hepatitis C Virus Infection (RESQUETI Study).
Recruiting
N/A
Interventional Study
Liver Disease Chronic
HEPATITIS C VIRUS CHRONIC INFECTION
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 69
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 26 (estimated)
- Sponsor
- University of Guadalajara · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this clinical trial is to evaluate whether a nutritional supplement containing resveratrol, quercetin, taurine, inulin, and whey protein improves biochemical and molecular markers, as well as clinical outcomes, in patients with liver disease related to chronic hepatitis C infection.
The study will compare the investigational supplement with an active control (whey protein alone) to…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Patients with liver disease secondary to chronic hepatitis C virus infection who attend the outpatient Hepatitis Clinic of the Gastroenterology Department at Hospital Civil Fray Antonio Alcalde.
Child-Pugh score \< 8 points. Age 18-69 years. Both sexes. Signed informed consent.…
Contacts
Juan Roberto Rodriguez-Echevarria, PhD
+52 33 18 23 13 10
roberto.rodriguez@academico.udg.mx
CONTACT